Lidocaine for systemic sclerosis: a double-blind randomized clinical trial

BACKGROUND: Systemic sclerosis (scleroderma; SSc) is an orphan disease with the highest case-specific mortality of any connective-tissue disease. Excessive collagen deposit in affected tissues is a key for the disease's pathogenesis and comprises most of the clinical manifestations. Lidocaine s...

Descripción completa

Detalles Bibliográficos
Autores principales: Riera, Rachel, Andrade, Luís EC, Souza, Alexandre WS, Kayser, Cristiane, Yanagita, Edison T, Trevisani, Virgínia FM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041650/
https://www.ncbi.nlm.nih.gov/pubmed/21299861
http://dx.doi.org/10.1186/1750-1172-6-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041650/
https://www.ncbi.nlm.nih.gov/pubmed/21299861
http://dx.doi.org/10.1186/1750-1172-6-5

Ejemplares similares